YOU WONT BELIEVE: 9 - You Need To See This

Pfizer agrees to offer discounted drugs through new federal website, Trump announces

President also said that company would offer medications to Medicaid at ‘most favored nation’ pricing

The Guardian - US · Sep 30, 2025

Pfizer agrees to lower prescription drug costs for Medicaid in a deal with Trump

Drugmaker Pfizer has agreed to lower drug costs and invest $70 billion in U.S. manufacturing under a deal struck with President Donald Trump's administration

The Independent UK · Sep 30, 2025

Pfizer Shares Are Trading Higher Tuesday: What's Going On?

Pfizer, Inc. (NYSE:PFE) shares are trading higher on Tuesday after The Washington Post reported that President Donald Trump will announce a drug-pricing deal with the company.

Benzinga · Sep 30, 2025

Asian shares trade mixed after US stocks set more records

Asian shares are trading mixed in the absence of key market-driving news in the region, after a seemingly relentless rally continued on Wall Street

The Independent UK · Sep 23, 2025

Metsera Stock Rockets After Pfizer's $7.3b — Should You Still Invest?

Metsera stock has soared after Pfizer announced a $7.3 billion acquisition, sparking investor buzz. Analysts are now weighing whether the biotech rally has more room to run or if buyers should stay cautious.

International Business Times UK · Sep 22, 2025

Pfizer eyes obesity drug market as it seals $4.9bn deal for Metsera

Pharma giant Pfizer is betting on obesity treatments as it looks for new markets following the success of its COVID-19 vaccine.

Euronews · Sep 22, 2025

Pfizer Tries To Revitalize Obesity Portfolio With $5 Billion Matsera Deal

Pfizer Inc. (NYSE:PFE) on Monday agreed to acquire Metsera, Inc. (NASDAQ:MTSR) to accelerate the next generation of medicines for obesity and cardiometabolic diseases.

Benzinga · Sep 22, 2025

Pfizer amps up push into obesity treatments with $4.9B deal for Metsera

Pfizer is doubling down on obesity treatments by spending $4.9 billion on the development-stage drugmaker Metsera

The Independent UK · Sep 22, 2025

Why the Recovery in Pfizer Stock Could Be Bigger Than Investors Expect

Pfizer is quietly laying the foundation for a new era of sustainable growth.

Barchart · Sep 22, 2025

Pfizer Reportedly Nears Metsera Acquisition Deal: PFE Stock Climbs In Monday Pre-Market

Pfizer Inc. (NYSE:PFE) stock climbed 1.54% in Monday pre-market amid reports that the company on the verge of acquiring Metsera Inc. (NASDAQ:MTSR), a developer of anti-obesity drugs.

Benzinga · Sep 22, 2025